John G. Schulte has served on the Board of Directors since August 1996. Mr. Schulte was appointed our President and Chief Executive Officer in January 2003. Mr. Schulte was formerly President and Chief Executive Officer of Consensus Pharmaceuticals, Inc., a privately held biotechnology Company from October 2001 to January 2003. Mr. Schulte had been President and Chief Executive Officer of Somnus Medical Technologies, Inc., a medical device company specializing in the design, development, manufacturing and marketing of minimally invasive medical devices for the treatment of upper airway disorders, from November 1998 until its acquisition by Gyrus Group, PLC, a European medical device company, in October 2001. Previously, Mr. Schulte was President of the Surgical Products Division of Genzyme Corporation, a medical device company specializing in anti-adhesion products for general surgery and cardiovascular medical devices and instruments, from July 1997 to October 1998. From November 1996 to June 1997, he served as Senior Vice President and General Manager of the International and Peripheral Division of Target Therapeutics, Inc., a medical device Company specializing in the treatment of vascular diseases of the brain, which was acquired by Boston Scientific Corporation in April 1997.read more ...read less ...
Disclaimer: PeekYou is not a consumer reporting agency per the Fair Credit Reporting Act. You may not use our site or service, or the information provided, to make decisions about employment, admission, consumer credit, insurance, tenant screening or any other purpose that would require FCRA compliance. For more information governing use of our site, please review our Terms of Service.
Copyright 2024 PeekYou.com. A Patent Pending People Search Process. All Rights Reserved.
By continuing to use our site, you consent to the placement of cookies on your browser and agree to the terms of our Privacy Policy. More details